Document is current
Any future updates will be listed below
-
Authors
Chiang, Nai-Jung
Hou, Ya-Chin
Tan, Kien Thiam
Tsai, Hung-Wen
Lin, Yih-Jyh
Yeh, Yi-Chen
Chen, Li-Tzong
Hou, Ya-Fu
Chen, Ming-Huang
Shan, Yan-Shen
-
Funding
Funding for this research was provided by:
Ministry of Science and Technology, Taiwan (MOST 109-2321-B-006-011, MOST 110-2745-B-006-001, MOST 110-2321-B-006-005)
Health Promotion Administration, Ministry of Health and Welfare (MOHW110-TDU-B-212-144026, MOHW110-TDU-B-211-124003, MOHW111-TDU-B-221-014015)
National Health Research Institutes (NHRI-106A1-PDCO-0217173, NHRI-107A1-CACO-02181811, NHRI-108A1-PDCO-0219193, A1-CAPP23-014)
National Health Research Institutes (CA-109-PP-23, CA-110-PP-22)
- License Information
-
More Information
Article History
Received: 17 January 2022
Accepted: 16 April 2022
First Online: 3 July 2022
Declarations
:
: YCH created and edited the graphical abstract using BioRender platform (). NJC received honorarium from AstraZeneca, Bayer, BMS/ONO, MSD, TTY Biopharm. LTC received honorariums from Taiho, TTY Biopharm and Eli Lilly. YSS received honorarium from AstraZeneca, Ipsen, Eli Lilly, Novartis, and TTY Biopharm.
: Not applicable.
: This study was approved by the Human Research Ethics Committees of National Cheng-Kung University Hospital (IRB number: B-ER-106-224) and Taipei Veterans General Hospital (IRB number: 2015-03-005BC).
: All authors had already reviewed and agreed to the concept of this manuscript. NJ Chiang, YC Hou, MH Chen, and YS Shan have full access to all data and take final responsibility for submission and publication of this work.
: Not applicable.
: Not applicable.
